Protillion Biosciences
- Biotech or pharma, therapeutic R&D

Protillion is a Stanford spinout backed by ARCH and Illumina Ventures, with a protein-on-a-chip tech that allows synthesis, direct binding measurements against multiple targets, and molecular optimization at a massive scale. The platform is being leveraged for an in-house immunology asset and we are partnering with teams that are interested in solving complex protein engineering problems.